Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $249,299 | 115 | 63.6% |
| Consulting Fee | $50,191 | 31 | 12.8% |
| Honoraria | $49,650 | 28 | 12.7% |
| Food and Beverage | $42,096 | 2,038 | 10.7% |
| Education | $914.29 | 16 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $81,805 | 288 | $0 (2024) |
| Amgen Inc. | $60,962 | 65 | $0 (2024) |
| Celgene Corporation | $50,889 | 71 | $0 (2019) |
| PFIZER INC. | $41,583 | 104 | $0 (2024) |
| VYNE Pharmaceuticals Inc. | $40,931 | 89 | $0 (2021) |
| Arcutis Biotherapeutics, Inc. | $31,800 | 72 | $0 (2024) |
| LEO Pharma Inc. | $17,098 | 158 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $15,294 | 12 | $0 (2018) |
| Aqua Pharmaceuticals | $14,365 | 159 | $0 (2017) |
| Verrica Pharmaceuticals Inc. | $9,276 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $56,880 | 287 | Arcutis Biotherapeutics, Inc. ($18,360) |
| 2023 | $65,237 | 304 | Galderma Laboratories, L.P. ($35,529) |
| 2022 | $28,226 | 230 | Amgen Inc. ($17,777) |
| 2021 | $52,892 | 244 | VYNE Pharmaceuticals Inc. ($24,185) |
| 2020 | $51,755 | 176 | VYNE Pharmaceuticals Inc. ($16,746) |
| 2019 | $34,935 | 268 | Galderma Laboratories, L.P. ($12,423) |
| 2018 | $39,193 | 300 | Celgene Corporation ($21,848) |
| 2017 | $63,033 | 419 | Celgene Corporation ($16,846) |
All Payment Transactions
2,228 individual payment records from CMS Open Payments — Page 1 of 90
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 12/20/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Inflammation | ||||||
| 12/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $34.90 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Immunology | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.36 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $2.69 | General |
| 12/16/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| 12/16/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug), DUOBRII | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Dermatology | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Immunology | ||||||
| 12/11/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $7.22 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.99 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $5.65 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $72.08 | General |
| Category: Dermatology | ||||||
| 12/06/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Inflammation & Immunology | ||||||
| 12/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $16.91 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.26 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $57.46 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 3,569 | 7,238 | $1.4M | $359,304 |
| 2022 | 19 | 3,471 | 7,113 | $1.4M | $373,092 |
| 2021 | 19 | 2,821 | 5,317 | $1.1M | $296,082 |
| 2020 | 15 | 2,211 | 4,062 | $857,110 | $222,586 |
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 666 | 922 | $461,000 | $92,887 | 20.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 730 | 1,045 | $203,775 | $79,219 | 38.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 180 | 296 | $111,000 | $45,144 | 40.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 511 | 705 | $211,500 | $29,226 | 13.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 194 | 243 | $54,675 | $26,637 | 48.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 424 | 3,079 | $153,950 | $19,109 | 12.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 202 | 215 | $75,250 | $15,694 | 20.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 243 | 285 | $42,750 | $13,386 | 31.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 108 | 108 | $27,000 | $9,544 | 35.3% |
| 10040 | Acne surgery | Office | 2023 | 54 | 54 | $17,550 | $5,576 | 31.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $13,000 | $5,536 | 42.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 26 | 26 | $9,100 | $4,448 | 48.9% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 27 | 27 | $8,775 | $2,946 | 33.6% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 20 | 23 | $13,800 | $2,849 | 20.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 46 | 46 | $10,350 | $2,670 | 25.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 37 | 42 | $7,350 | $2,025 | 27.5% |
| 69100 | Biopsy of ear | Office | 2023 | 17 | 17 | $5,950 | $1,394 | 23.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 20 | 27 | $6,075 | $983.76 | 16.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 24 | 38 | $380.00 | $29.35 | 7.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 654 | 917 | $458,500 | $96,992 | 21.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 691 | 966 | $188,370 | $77,051 | 40.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 205 | 326 | $122,250 | $51,282 | 41.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 212 | 272 | $61,200 | $30,047 | 49.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 476 | 654 | $196,200 | $29,058 | 14.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 384 | 2,978 | $148,900 | $18,922 | 12.7% |
About Dr. Michael Fastenberg, M.D
Dr. Michael Fastenberg, M.D is a Dermatology healthcare provider based in Smithtown, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1073735593.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Fastenberg, M.D has received a total of $392,151 in payments from pharmaceutical and medical device companies, with $56,880 received in 2024. These payments were reported across 2,228 transactions from 52 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($249,299).
As a Medicare-enrolled provider, Fastenberg has provided services to 12,072 Medicare beneficiaries, totaling 23,730 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Smithtown, NY
- Active Since 05/03/2007
- Last Updated 01/26/2011
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1073735593
Products in Payments
- Otezla (Drug) $111,612
- EUCRISA (Drug) $41,409
- AKLIEF (Drug) $40,989
- AMZEEQ (Drug) $25,863
- Zoryve (Drug) $18,360
- EPIDUO FORTE (Drug) $16,394
- Finacea (Drug) $15,294
- ZILXI (Drug) $15,068
- YCANTH (Drug) $9,276
- ENSTILAR (Drug) $7,302
- PICATO (Drug) $4,461
- FINACEA (Drug) $4,436
- Verdeso (Drug) $4,323
- VTAMA (Drug) $3,639
- SORILUX (Drug) $2,900
- Altabax (Drug) $2,254
- TWYNEO (Drug) $2,117
- COSENTYX (Biological) $1,635
- TREMFYA (Drug) $1,626
- Neo-Synalar (Drug) $1,545
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Smithtown
Dr. Daniel Siegel, M.d, M.D
Dermatology — Payments: $657,817
Ms. Tamara Koss, Md, MD
Dermatology — Payments: $26,724
Dr. Donna Serure, D.o, D.O
Dermatology — Payments: $11,622
Dr. Audra Malerba, D.o, D.O
Dermatology — Payments: $10,668
Barry Solomon, Md, Jd, Faad, MD, JD, FAAD
Dermatology — Payments: $3,753
Lawrence Lieblich, Md, MD
Dermatology — Payments: $1,328